Low-dose computed tomography (LDCT) screening trials have based their risk selection algorithm on age and tobacco exposure, but never on pulmonary risk-related biomarkers. In the present study, the baseline inflammatory status, measured by C-reactive protein (CRP) level, and lung function, measured by forced expiratory volume in 1s (FEV1), were tested as independent predictors of all-cause mortality in LDCT-screening participants. Between 2000 and 2010, 4413 volunteers were enrolled in two LDCT-screening trials, with evaluable baseline CRP and FEV1 values: 2037 were included in the discovery set and 2376 were included in the validation set. The effect of low FEV1 or high CRP alone or combined was evaluated by Kaplan-Meier mortality curves and hazard ratio (HR) with 95% confidence interval (CI) by fitting Cox proportional hazards models. The overall mortality risk was significantly higher in participants with FEV1 of up to 90% (HR: 2.13, CI: 1.43-3.17) or CRP more than 2mg/l (HR: 3.38, CI: 1.60-3.54) and was still significant in the fully adjusted model. The cumulative 10-year probability of death was 0.03 for participants with FEV1 of more than 90% and CRP up to 2mg/l, 0.05 with only FEV1 of up to 90% or CRP above 2mg/l, and 0.12 with FEV1 of up to 90% and CRP above 2mg/l. This predictive performance was confirmed in the two external validation cohorts with 10-year mortality rates of 0.06, 0.12, and 0.14, and 0.03, 0.07, and 0.14, respectively. Baseline inflammatory status and lung function reduction are independent predictors of all-cause long-term mortality in LDCT-screening participants. CRP and FEV1 could be used to select higher-risk individuals for future LDCT screening and preventive programs

Pastorino, U., Morelli, D., Marchianò, A., Sestini, S., Suatoni, P., Taverna, F., et al. (2018). Inflammatory status and lung function predict mortality in lung cancer screening participants. EUROPEAN JOURNAL OF CANCER PREVENTION, 27(4), 289-295 [10.1097/CEJ.0000000000000342].

Inflammatory status and lung function predict mortality in lung cancer screening participants

CANTARUTTI, ANNA
Penultimo
;
CORRAO, GIOVANNI
Ultimo
2018

Abstract

Low-dose computed tomography (LDCT) screening trials have based their risk selection algorithm on age and tobacco exposure, but never on pulmonary risk-related biomarkers. In the present study, the baseline inflammatory status, measured by C-reactive protein (CRP) level, and lung function, measured by forced expiratory volume in 1s (FEV1), were tested as independent predictors of all-cause mortality in LDCT-screening participants. Between 2000 and 2010, 4413 volunteers were enrolled in two LDCT-screening trials, with evaluable baseline CRP and FEV1 values: 2037 were included in the discovery set and 2376 were included in the validation set. The effect of low FEV1 or high CRP alone or combined was evaluated by Kaplan-Meier mortality curves and hazard ratio (HR) with 95% confidence interval (CI) by fitting Cox proportional hazards models. The overall mortality risk was significantly higher in participants with FEV1 of up to 90% (HR: 2.13, CI: 1.43-3.17) or CRP more than 2mg/l (HR: 3.38, CI: 1.60-3.54) and was still significant in the fully adjusted model. The cumulative 10-year probability of death was 0.03 for participants with FEV1 of more than 90% and CRP up to 2mg/l, 0.05 with only FEV1 of up to 90% or CRP above 2mg/l, and 0.12 with FEV1 of up to 90% and CRP above 2mg/l. This predictive performance was confirmed in the two external validation cohorts with 10-year mortality rates of 0.06, 0.12, and 0.14, and 0.03, 0.07, and 0.14, respectively. Baseline inflammatory status and lung function reduction are independent predictors of all-cause long-term mortality in LDCT-screening participants. CRP and FEV1 could be used to select higher-risk individuals for future LDCT screening and preventive programs
Articolo in rivista - Articolo scientifico
Epidemiology; Oncology; Public Health, Environmental and Occupational Health; Cancer Research
English
289
295
7
Pastorino, U., Morelli, D., Marchianò, A., Sestini, S., Suatoni, P., Taverna, F., et al. (2018). Inflammatory status and lung function predict mortality in lung cancer screening participants. EUROPEAN JOURNAL OF CANCER PREVENTION, 27(4), 289-295 [10.1097/CEJ.0000000000000342].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/156275
Citazioni
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
Social impact